GME
46
4
CVS
58
-2
PSX
57
-7
MSI
57
5
AVGO
40
-2
SLB
42
-2
DVA
52
-2
GPC
56
2
PG
37
2
ADM
44
-9
YUM
58
2
PEP
41
-7
MMC
50
2
EFX
50
3
HES
54
-2
IRM
31
3
AMAT
63
-3
IPG
53
6
STI
35
-5
NAVI
49
2
GME
46
4
CVS
58
-2
PSX
57
-7
MSI
57
5
AVGO
40
-2
SLB
42
-2
DVA
52
-2
GPC
56
2
PG
37
2
ADM
44
-9
YUM
58
2
PEP
41
-7
MMC
50
2
EFX
50
3
HES
54
-2
IRM
31
3
AMAT
63
-3
IPG
53
6
STI
35
-5
NAVI
49
2
Financhill
Back

Novo Nordisk AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

NONOF
Novo Nordisk AS

Last Price:
$65.19
Seasonality Move:
0.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 21.9% based on the past 16 years of stock performance.
  • Novo Nordisk AS has risen higher in 12 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NONOF] share price is $68.40. The Score for NONOF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 21.9% based on the past 16 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
37
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 12 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Novo Nordisk AS Stock Price History

Is NONOF stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
141.19
52-Week Low:
55.28

Prediction Charts

Market Cap:
303.9B
Price in USD:
68.40
Volume:
4.4K
Beta:
0.54

Technical Analysis

SMA50:
69.76
SMA100:
71.47
SMA200:
85.93
52-Wk Change:
-52.04%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 68.40 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 68.00 66.48 68.90 66.14
Jun-27 65.95 68.25 70.00 65.95
Jun-30 70.67 69.48 71.31 67.35
Jul-1 68.57 67.60 70.29 67.10
Jul-2 69.00 68.97 71.53 67.10
Jul-3 66.63 69.49 71.05 66.63
Jul-7 68.49 70.12 71.00 68.07
Jul-8 65.45 67.96 71.36 65.45
Jul-9 70.96 69.82 70.96 68.00
Jul-10 69.75 70.00 72.20 68.26
Jul-11 71.62 68.85 71.62 67.77
Jul-14 67.00 67.01 70.08 67.00
Jul-15 67.50 67.14 69.11 66.94
Jul-16 66.64 68.40 69.45 66.00

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.